Table 2. Baseline Characteristics of the Female Population According to BMI.
| Variable | 18.5≤BMI<25 n=723 |
25≤BMI<30 n=261 |
30≤BMI n=57 |
p for trend |
|---|---|---|---|---|
| BMI (kg/m2) | 21.9±1.7 | 26.6±1.3 | 32.8±2.7 | <0.001 |
| Age (yr) | 70.4±12.9 | 67.3±12.9 | 64.8±14.4 | 0.002 |
| SBP (mm Hg) | 128.8±27.6 | 130.7±27.6 | 128.4±25.7 | 0.918 |
| Heart rate (BPM) | 91.3±24.5 | 92.1±27.1 | 89.1±19.8 | 0.540 |
| Ischemic HF | 272 (37.9) | 105 (41.0) | 25 (43.9) | 0.247 |
| De novo HF | 430 (63.2) | 150 (60.7) | 34 (64.2) | 0.720 |
| Ejection fraction | 30.8±8.7 | 31.4±8.1 | 32.1±9.1 | 0.272 |
| LVEDD | 57.6±10.6 | 57.7±13.2 | 59.4±13.7 | 0.531 |
| LVESD | 47.4±11.5 | 47.0±12.2 | 18.8±14.0 | 0.585 |
| E/E' | 23.4±12.7 | 23.2±15.8 | 17.6±5.8 | 0.095 |
| LBBB | 72 (11.0) | 17 (7.1) | 6 (11.5) | 0.311 |
| Atrial fibrillation | 161 (23.8) | 55 (22.3) | 15 (28.3) | 0.843 |
| NYHA class 3 or 4 | 477 (72.1) | 171 (69.5) | 44 (80.0) | 0.699 |
| Past history | ||||
| HTN | 385 (53.3) | 152 (58.2) | 36 (63.2) | 0.060 |
| DM | 247 (34.2) | 117 (44.8) | 27 (47.4) | 0.001 |
| Stroke | 53 (10.6) | 27 (14.1) | 1 (2.5) | 0.823 |
| Previous MI | 108 (14.9) | 46 (17.6) | 8 (14.0) | 0.593 |
| COPD | 20 (2.9) | 5 (2.0) | 1 (1.9) | 0.419 |
| CKD | 54 (7.5) | 36 (13.8) | 8 (14.0) | 0.002 |
| Laboratory finding | ||||
| Hemoglobin (g/dL) | 11.7±2.0 | 12.0±2.0 | 12.4±2.0 | 0.011 |
| Na (mmol/L) | 138.2±5.3 | 139.0±4.7 | 137.9±4.7 | 0.704 |
| Glucose (mg/dL) | 166.8±92.6 | 173.3±95.8 | 175.6±80.5 | 0.503 |
| BUN (mg/dL) | 23.8±14.3 | 25.1±15.1 | 15.2±14.1 | 0.489 |
| Cr (mg/dL) | 1.3±1.2 | 1.5±1.4 | 1.5±1.3 | 0.398 |
| NT-proBNP (pg/mL) | 10317.6±10426.8 | 7956.2±8981.9 | 6192.7±8103.5 | 0.018 |
| Discharge medication | ||||
| ACEi or ARB | 563 (77.9) | 206 (78.9) | 48 (84.2) | 0.320 |
| Beta blocker | 393 (54.4) | 156 (59.8) | 31 (54.4) | 0.332 |
| MRA | 371 (51.3) | 140 (53.6) | 27 (47.4) | 0.983 |
BMI, body mass index; SBP, systolic blood pressure; BPM, beats per minute; HF, heart failure; LBBB, left bundle branch block; NYHA, New York Heart Association; HTN, hypertension; DM, diabetes mellitus; MI, myocardial infarction; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; BUN, blood urea nitrogen; Cr, creatinine; BNP, brain natriuretic peptides; NT-proBNP, N terminal pro brain natriuretic peptides; ACEi, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; MRA, mineralocorticoid receptor antagonist.
Values are expressed as mean±SD or n (%).